NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/23/2025
Back to search
Official data from USPTO
WUXI TIDES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WUXI TIDES
ST13
US500000097775103Class
5, 42
Filing
97775103
Registration
7961204
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
09/23/2025
Trademark type
Word
Nice classes
5, 42
Filing date
01/31/2023
Registration date
09/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2025
Last transaction
09/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/29/2023
First use in commerce
04/17/2023
Drawing code
4
Owner type
16
Owner location
Shanghai, CN
Examiner
KETCHUM, BRENDAN J
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Shanghai SynTheAll Pharmaceutical Co., Ltd
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cancerautoimmune diseasecoagulation disorderinfectious disease; Medicines for human purposesmedicines for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Raw material medicinemedicines for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases; Pharmaceutical preparationsfor the treatment of cancersinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disorders; pharmaceutical preparationsantivirals; Chemico-pharmaceutical preparations for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases; Biological preparations for medical purposes for the treatment of cancer; Chemical preparations for the diagnosis of pregnancy; Chemical preparations for pharmaceutical or medical purposesfor cancersinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disorders healthcare and clinical applications; Chemical preparations for medical purposeschemical reagents for medical purposes; Chemical preparations for medical purposes for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases; Diagnostic preparations for medical purposes; Nutritional supplements; Drugs for medical purposes for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases; Reagent paper for medical purposes; Medical reagent; Disinfectants for hygiene purposes; Cultures of microorganisms for medical use; Biomedicines for the treatment of cancercardiovascularhematologicneurological; gastrointestinal and genetic diseases; Adjuvants for medical purposes; Vaccines; Veterinary preparations for the treatment of cancercardiovascularhematologicneurologicalgastrointestinal and genetic diseases
Class 42
Computer programming; Material testing; Technical research in the field of pharmaceutical studies; Research and development of new products for others; Technology consultancy in the field of cybersecurity; Chemical analysis; Chemistry serviceschemistry consultation; Chemical research; Biological research; conducting clinical trials for othersbeing for scientific and medical research; Quality checking and testingquality control for others; Scientific laboratory services; Genome structure and function analysis; Gene screeningDNA screening for scientific research purpose; Biomedical research services; Stem cell research service; Drug research and development servicespharmaceutical research; cell culture services for scientific research purposesfor others; Design and development of computer hardware and software; Development and creation of computer programs for data processing; Computer programming in the field of medical treatment; Product quality testing; assessment of quality of products; Scientific research; Surveying; Bacteriological research; The designproduction in the nature of designmaintenance of a computer program; Computer software design; Computer technology consultancy in the field of engineering; Information technology consulting relating to computer network design; Artificial intelligence technology consulting; Research on artificial intelligence technology; Research and development of new products; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Drug evaluationpharmaceutical product evaluation; Vaccine research and development services; Cancer medicine research; Biotechnology research; Drug testing being testing of pharmaceuticals; Pharmaceutical research; Cancer scientific research for medical purposes; Development and Test of Chemical production methods; Implementing of early evaluation in the field of new drugsproduct quality testing; Biochemical research and analysis; Chemical analysis evaluation service; Chemical synthesis evaluation service; scientific research of the mode of action of chemical combinations on animals
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/23/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/03/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/29/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/08/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/08/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/22/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/22/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/22/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/22/2025
IUAF
USE AMENDMENT FILED
07/04/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2023
GNRT
NON-FINAL ACTION E-MAILED
11/07/2023
CNRT
NON-FINAL ACTION WRITTEN
11/07/2023
DOCK
ASSIGNED TO EXAMINER
10/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/18/2023
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
02/03/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/03/2023
NWAP
NEW APPLICATION ENTERED
02/03/2023
Continuous trademark protection
Get notified about every new filing that threatens WUXI TIDES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.